Evidence map›Paper›PMID 41247405›Full record

ArticleAnnals of hematology2025

Combination therapy based on venetoclax overcomes resistance to all-trans retinoic acid and arsenic trioxide in a variant acute promyelocytic leukemia with TNRC18::RARA fusion.

Wenjing Ding, Jun Zhao, Zheng Wang, Yongjing Liu, Man Wang, Hongjie Shen, Yun Chen, Jinyan Huang, Dong Li, Suning Chen and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wenjing Ding *Weifang People's Hospital, Shandong Second Medical University, Weifang, P.R. China.
Jun Zhao *Central Hospital Affiliated to Shandong First Medical University, Jinan, P.R. China.
Zheng Wang *Suzhou Jsuniwell Medical Laboratory, Suzhou, P.R. China.
Yongjing LiuBiomedical Big Data Center, the First Affiliated Hospital of Zhejiang University, Zhejiang University, Hangzhou, P.R. China.
Man WangJiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Shizi Street 188, Suzhou, PR, 215006, P.R. China.
Hongjie ShenJiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Shizi Street 188, Suzhou, PR, 215006, P.R. China.
Yun ChenCentral Hospital Affiliated to Shandong First Medical University, Jinan, P.R. China.
Jinyan HuangBiomedical Big Data Center, the First Affiliated Hospital of Zhejiang University, Zhejiang University, Hangzhou, P.R. China.
Dong LiNanjing BenQ Medical Center, the Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, P.R. China.
Suning ChenJiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Shizi Street 188, Suzhou, PR, 215006, P.R. China. chensuning@sina.com.
Lijun WenJiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Shizi Street 188, Suzhou, PR, 215006, P.R. China. sudawlj@163.com.

Funding

National Key Research and Development Program of China 2022YFC2502701)National Natural Science Foundation of China 82470166
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41247405
PMCPMC12764660

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.